NDC 51079-434-01 - Megestrol Acetate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51079-434
- Requested NDC
- 51079-434-01
- Package NDCs from labels
- 51079-434-01, 51079-434-20
- Manufacturer
- Mylan Institutional Inc.
- Effective date
- 2019-11-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Megestrol Acetate Tablets USP Rx only | Mylan Institutional Inc. | 2019-11-06 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51079-434-01 | EA - Each | 51079-434 | 72ebef1a-3959-4456-ac59-efcb287ffcf6 | 1 | 2012-07-24 |
| 51079-434-20 | EA - Each | 51079-434 | 78eb4639-f6b9-4bad-b3d0-99bc6838f64d | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| MEGESTROL ACETATE | ACTIVE INGREDIENT | TJ2M0FR8ES | MEGESTROL ACETATE TABLET [MYLAN INSTITUTIONAL INC.] | 2 | |
| MEGESTROL | ACTIVE MOIETY | EA6LD1M70M | MEGESTROL ACETATE TABLET [MYLAN INSTITUTIONAL INC.] | 2 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | MEGESTROL ACETATE TABLET [MYLAN INSTITUTIONAL INC.] | 2 | |
| CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE | INACTIVE INGREDIENT | O7TSZ97GEP | MEGESTROL ACETATE TABLET [MYLAN INSTITUTIONAL INC.] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | MEGESTROL ACETATE TABLET [MYLAN INSTITUTIONAL INC.] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | MEGESTROL ACETATE TABLET [MYLAN INSTITUTIONAL INC.] | 2 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | MEGESTROL ACETATE TABLET [MYLAN INSTITUTIONAL INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Megestrol Acetate | MEGESTROL ACETATE | ATLANTIC BIOLOGICALS CORP. | 01119031-9943-4afb-8b45-cb71682f0482 | 2026-07-09 | Warnings, Adverse reactions | TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Preferred Pharmaceuticals Inc. | edef65d1-d583-4cee-bb9a-515be84ac51d | 2026-06-15 | Warnings, Adverse reactions | TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Upsher-Smith Laboratories, LLC | 2dc921d5-e423-4379-a345-151e87d13651 | 2026-04-14 | Warnings, Adverse reactions | TJ2M0FR8ES |
| BIS II Tooth | PRECIPITATED CALCIUM CARBONATE, TOCOPHEROL ACETATE, ALUMINIUM CHLOROHYDROXY ALLANTOINATE, DIBASIC CALCIUM PHOSPHATE HYDRATE | Jewoo Medical CO.,LTD | 49e5eeaa-7506-f42a-e063-6294a90a2864 | 2026-02-03 | Warnings | O7TSZ97GEP |
| BIS II Tooth | PRECIPITATED CALCIUM CARBONATE, TOCOPHEROL ACETATE, ALUMINIUM CHLOROHYDROXY ALLANTOINATE, DIBASIC CALCIUM PHOSPHATE HYDRATE | Jewoo Medical CO.,LTD | 49f94296-3e74-1828-e063-6394a90a97d5 | 2026-02-03 | Warnings | O7TSZ97GEP |
| BIS II Tooth | PRECIPITATED CALCIUM CARBONATE, TOCOPHEROL ACETATE, ALUMINIUM CHLOROHYDROXY ALLANTOINATE, DIBASIC CALCIUM PHOSPHATE HYDRATE | Jewoo Medical CO.,LTD | 49f942e6-ceef-5505-e063-6394a90a113f | 2026-02-03 | Warnings | O7TSZ97GEP |
| Megestrol Acetate | MEGESTROL ACETATE | Major Pharmaceuticals | e44cf173-991b-43cf-93f2-e0efaa4cc29a | 2026-01-15 | Warnings, Adverse reactions | TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Natco Pharma USA LLC | 582cff8a-1def-43d6-ba7e-dce49e3e9f27 | 2026-01-15 | Warnings, Adverse reactions | TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | American Health Packaging | 2921731a-6866-4dc8-8f6b-b636abf7bcf8 | 2026-01-05 | Warnings, Adverse reactions | TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | PAI Holdings, LLC dba PAI Pharma | 2d5b58cd-cbb1-4f5c-b13f-63185c0f8e31 | 2025-10-17 | Warnings, Adverse reactions | TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Major Pharmaceuticals | 2c755c6b-32e9-4029-8b70-855007f7375b | 2025-09-15 | Warnings, Adverse reactions | 860221 TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Kesin Pharma Corporation | 3bc8708e-a52d-fda2-e063-6294a90a0fbc | 2025-09-02 | Warnings, Adverse reactions | TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Xttrium Laboratories, Inc. | 3169f883-4076-32ce-e063-6394a90a4925 | 2025-07-24 | Warnings, Adverse reactions | TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Bryant Ranch Prepack | dd6617df-0876-4fc5-8435-b53d29ccc1ae | 2025-03-31 | Warnings, Adverse reactions | 860221 TJ2M0FR8ES |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| Megestrol Acetate | MEGESTROL ACETATE | Strides Pharma Science Limited | 8ec70070-da70-4a38-9d58-cf2278517661 | 2025-02-24 | Warnings, Adverse reactions | 860215 860221 TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Bryant Ranch Prepack | 9b764cf3-4756-4f0e-b747-421d71674313 | 2025-01-17 | Warnings, Adverse reactions | ANDA074621 860221 TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Golden State Medical Supply, Inc. | 19c33213-7919-208d-e063-6394a90a0f08 | 2024-05-31 | Warnings, Adverse reactions | TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Precision Dose Inc. | bf0d54c5-b813-4f2e-9a37-cbea332cfe53 | 2024-03-28 | Warnings, Adverse reactions | TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Precision Dose Inc. | d0ad931e-4e3e-48bf-9949-77d6971da6e6 | 2024-03-28 | Warnings, Adverse reactions | TJ2M0FR8ES |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.